<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04549974</url>
  </required_header>
  <id_info>
    <org_study_id>ICM 2020-2719</org_study_id>
    <nct_id>NCT04549974</nct_id>
  </id_info>
  <brief_title>Characterization of Myocardial Blood Flow During Heat Exposure</brief_title>
  <acronym>PET-Heat</acronym>
  <official_title>Characterization of the Increase and Distribution of Myocardial Blood Flow During Heat Exposure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montreal Heart Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Montreal Heart Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the increase in myocardial blood flow during heat&#xD;
      exposure and how this response is affected by age and coronary artery disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      As a result of climate change, heat waves are more frequent and of longer duration. These&#xD;
      heat waves are associated with a higher risk of hospitalization and mortality in vulnerable&#xD;
      populations such as people with cardiovascular disease or cardiovascular risk factors. It has&#xD;
      been hypothesized that this observation may be explained by the cardiovascular demands&#xD;
      imposed by heat exposure.&#xD;
&#xD;
      Heat exposure requires increased cardiac work that may place individuals with cardiovascular&#xD;
      disease at risk of ischemic events if the metabolic demand is not compensated by adequate&#xD;
      blood supply. However, the extent to which cardiac work increases during heat exposure&#xD;
      remains unknown. The aim of this study is to test the hypothesis that heat exposure increases&#xD;
      myocardial blood flow and that this increase is affected by age and coronary artery disease.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 25, 2020</start_date>
  <completion_date type="Anticipated">July 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Global myocardial blood flow</measure>
    <time_frame>Change from baseline to an increase in internal body temperature of 1.5 degrees Celsius, estimated average = 90 minutes</time_frame>
    <description>Measured by PET imaging with 82rubidium</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Myocardial blood flow distribution</measure>
    <time_frame>Change from baseline to an increase in internal body temperature of 1.5 degrees Celsius, estimated average = 90 minutes</time_frame>
    <description>Measured by PET imaging with 82rubidium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>Change from baseline to an increase in internal body temperature of 1.5 degrees Celsius, estimated average = 90 minutes</time_frame>
    <description>Measured by electrocardiogram</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic and diastolic blood pressure</measure>
    <time_frame>Change from baseline to an increase in internal body temperature of 1.5 degrees Celsius, estimated average = 90 minutes</time_frame>
    <description>Measured by automated auscultation of the brachial artery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body weight</measure>
    <time_frame>Measured before and after heat exposure, estimated average = 120 minutes</time_frame>
    <description>Measured with a scale</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Hot Weather; Adverse Effect</condition>
  <condition>Healthy</condition>
  <condition>Coronary Artery Disease</condition>
  <condition>Aging</condition>
  <arm_group>
    <arm_group_label>Passive heat exposure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Heat exposure</intervention_name>
    <description>Participants will be exposed to heat exposure via a water-perfused suit to increase internal body temperature by 1.5 degrees Celsius.</description>
    <arm_group_label>Passive heat exposure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria for Healthy Participants:&#xD;
&#xD;
          -  Age between 18-40 years or 60-80 years&#xD;
&#xD;
          -  Non-smoker (≥1 year)&#xD;
&#xD;
          -  Non-diabetic&#xD;
&#xD;
          -  Normal kidney function&#xD;
&#xD;
          -  Body Mass Index &lt;30 kg/m2&#xD;
&#xD;
          -  Resting blood pressure &lt;140/&lt;90 mmHg&#xD;
&#xD;
          -  Resting heart rate &lt;100 bpm&#xD;
&#xD;
        Inclusion Criteria for Participants with Coronary Artery Disease:&#xD;
&#xD;
          -  Age between 60-80 years old&#xD;
&#xD;
          -  History of angiographic coronary disease (≥70% arterial diameter narrowing of at least&#xD;
             one major epicardial coronary artery) and/or prior coronary revascularization and/or&#xD;
             documented prior acute coronary syndrome and/or perfusion defect during stress testing&#xD;
&#xD;
          -  Stable medications (≥4 weeks) prior to enrollment&#xD;
&#xD;
        Exclusion Criteria for Healthy Participants:&#xD;
&#xD;
          -  Diagnosis of heart, vascular, respiratory, neurological or metabolic disease and/or a&#xD;
             prescription of medication for the treatment of these diseases&#xD;
&#xD;
          -  Pregnancy or lactation&#xD;
&#xD;
          -  Dyslipidemia not controlled by medication&#xD;
&#xD;
        Exclusion Criteria for Participants with Coronary Artery Disease:&#xD;
&#xD;
          -  Recent hospitalization (&lt;3 months) related to coronary artery disease&#xD;
&#xD;
          -  Unstable angina (&lt;3 months)&#xD;
&#xD;
          -  Recent coronary artery bypass surgery (&lt;3 months)&#xD;
&#xD;
          -  Left branch block&#xD;
&#xD;
          -  Ejection fraction &lt;40% and/or clinical signs of heart failure&#xD;
&#xD;
          -  Severe valvular heart disease&#xD;
&#xD;
          -  Hypertension not controlled by medication&#xD;
&#xD;
          -  Diabetes not controlled by medication and/or serious complications related to diabetes&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Gagnon, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montreal Heart Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Daniel Gagnon, PhD</last_name>
    <phone>514-374-1480</phone>
    <phone_ext>4205</phone_ext>
    <email>daniel.gagnon.3@umontreal.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hadiatou Barry, MSc</last_name>
    <phone>514-374-1480</phone>
    <phone_ext>4265</phone_ext>
    <email>hadiatou.barry@umontreal.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Montreal Heart Institute</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H1T1C8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Gagnon, PhD</last_name>
      <phone>1-514-374-1480</phone>
      <phone_ext>4205</phone_ext>
      <email>daniel.gagnon.3@umontreal.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>August 25, 2020</study_first_submitted>
  <study_first_submitted_qc>September 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2020</study_first_posted>
  <last_update_submitted>May 10, 2021</last_update_submitted>
  <last_update_submitted_qc>May 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Montreal Heart Institute</investigator_affiliation>
    <investigator_full_name>Daniel Gagnon</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Heat</keyword>
  <keyword>PET imaging</keyword>
  <keyword>Myocardial blood flow</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

